Carmat SA (EPA:ALCAR)

Market Cap	29.49M
Revenue (ttm)	7.34M
Net Income (ttm)	-51.40M
Shares Out	62.08M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	346,258
Average Volume	905,870
Open	0.4750
Previous Close	0.4750
Day's Range	0.4605 - 0.4950
52-Week Range	0.2300 - 2.6500
Beta	1.37
RSI	55.15
Earnings Date	Sep 30, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 153
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.